Lecanemab Alzheimer's therapy approved in Europe

৪ দিন আগে ৪

The antibody lecanemab is the first authorized therapy in Europe that targets the underlying process of Alzheimer's, rather than only treating symptoms.

সম্পূর্ণ পড়ুন